Funding
Seed+ · Biotech

Avenue Biosciences raises $5.7M Seed+ financing

Avenue Biosciences raised $5.7 million in Seed+ financing announced in January.

Updated Oct 16, 2026By RoundOS Funding desk

Balnord, Tesi, Voima Ventures, Inventure, the University of Helsinki and Dimerent are among its investors.

The company develops high-throughput protein engineering technology for biologics manufacturing.

Funding history

Seed+ · This round$5.7M

Sources

  1. Avenue Biosciencesprojectstartups.com
  2. tech.eu

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related